Mon, Jun 4, 2012 -- 10:00 AM
Preventing Alzheimer's

Sebastien Bozon/AFP/Getty Images
A woman, suffering from Alzheimer's desease, walks in a corridor on March 18, 2011 in a retirement home.
A new trial of an Alzheimer's drug will test whether it can prevent the onset of the disease in people who are genetically predisposed to get it. If the drug is successful, there is hope -- but no guarantee -- that it could prevent Alzheimer's among the general public. We discuss the trial and its possible implications.
Host: Dave Iverson
Guests:
- Eric Reiman, CEO of Banner Research and executive director of Banner Alzheimer's Institute, a nonprofit dedicated to preventing Alzheimer's that is one of the study's leaders
- Geoffrey Kerchner, assistant professor of neurology at the Stanford School of Medicine
- William Fisher, CEO of the Alzheimer's Association of Northern California and Northern Nevada
Please ensure that all comments adhere to our community guidelines. We reserve the right to edit or remove comments that do not follow these guidelines.
Also, please note that your comments could be read on air. We may edit them for clarity or brevity, and we will use only your first name to identify you on the air.
Also, please note that your comments could be read on air. We may edit them for clarity or brevity, and we will use only your first name to identify you on the air.


